ArticleHepatology communications2026
Preclinical development of mesothelin-targeting CAR T cells for the treatment of cholangiocarcinoma.
Jinchutha Duangdara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it